Acemetacin-induced fixed drug eruption | Zendy

Filiz Cebeci | Zendy; Şirin Yaşar | Zendy; Sema Aytekin | Zendy; Pembegül Güneş | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Acemetacin-induced fixed drug eruption

Author(s) -

Filiz Cebeci,

Şirin Yaşar,

Sema Aytekin,

Pembegül Güneş

Publication year - 2016

Publication title -

indian journal of pharmacology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.286

H-Index - 59

eISSN - 1998-3751

pISSN - 0253-7613

DOI - 10.4103/0253-7613.178824

Subject(s) - nonsteroidal , medicine , prodrug , drug eruption , drug , adverse effect , antibiotics , pharmacology , chemistry , biochemistry

Fixed drug eruption (FDE) is an adverse effect observed with various drugs such as nonsteroidal anti-inflammatory drugs (NSAIDs) and various antibiotics. Acemetacin, a prodrug of indomethacin, is an NSAID licensed for use in rheumatic disease and other musculoskeletal disorders. We present a case of acemetacin-induced FDE in a 49-year-old woman. To the best of our knowledge, this is the second case report detailing clinical and histopathological findings of a patient with FDE caused by acemetacin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research